Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹202Cr
Rev Gr TTM
Revenue Growth TTM
290.32%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

TRANSCHEM
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | | | | | | | | 490.2 | | | -100.0 |
| 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 3 | 0 | 1 | 1 |
Operating Profit Operating ProfitCr |
| | | | | -112.2 | | | -161.9 | -20.3 | | | |
Other Income Other IncomeCr | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 |
| 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | -28.1 | 51.8 | 130.9 | 860.0 | 204.9 | 95.3 | 48.5 | 21.9 | -41.6 | -40.4 | -52.8 | -61.9 |
| | | | | 304.9 | | | 661.9 | 30.2 | | | |
| 0.3 | 0.7 | 0.8 | 0.9 | 1.0 | 1.4 | 1.2 | 1.1 | 0.6 | 0.8 | 0.6 | 0.4 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | | | | | | | | | | 541.6 | -8.0 |
| 1 | 1 | 1 | 2 | 1 | 1 | 2 | 3 | 2 | 2 | 4 | 5 |
Operating Profit Operating ProfitCr |
| | | | | | | | | | -423.4 | -55.6 | -116.5 |
Other Income Other IncomeCr | 2 | 2 | 2 | 2 | 3 | 3 | 27 | 7 | 4 | 7 | 9 | 7 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | -1 | 1 | 1 | 25 | 4 | 3 | 6 | 7 | 4 |
| 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 1 |
|
| 114.7 | -60.4 | -567.5 | -443.8 | 125.6 | 34.3 | 5,796.5 | -88.1 | -56.9 | 239.8 | 24.3 | -43.9 |
| | | | | | | | | | 1,025.2 | 198.7 | 121.1 |
| 0.1 | 0.0 | -0.2 | -1.0 | 0.3 | 0.3 | 19.7 | 2.3 | 1.0 | 3.4 | 4.3 | 2.4 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 |
| 26 | 26 | 26 | 25 | 26 | 25 | 51 | 54 | 54 | 63 | 67 | 69 |
Current Liabilities Current LiabilitiesCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Non Current Liabilities Non Current LiabilitiesCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 27 | 28 | 29 | 30 | 28 | 30 | 55 | 58 | 58 | 67 | 78 | 79 |
Non Current Assets Non Current AssetsCr | 11 | 10 | 9 | 7 | 10 | 7 | 9 | 9 | 8 | 9 | 2 | 2 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 1 | 1 | 1 | -20 | 10 | -1 | -28 | 22 | 1 | -39 | 36 |
Investing Cash Flow Investing Cash FlowCr | -1 | 0 | -2 | 20 | 6 | 1 | 23 | 1 | -1 | 5 | 6 |
Financing Cash Flow Financing Cash FlowCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Free Cash Flow Free Cash FlowCr | 1 | 1 | 1 | -20 | 11 | -1 | -2 | 22 | 1 | -39 | 37 |
| 798.2 | 2,312.1 | -252.7 | 1,663.5 | 3,388.8 | -154.6 | -114.8 | 763.9 | 98.5 | -935.1 | 688.9 |
CFO To EBITDA CFO To EBITDA% | -121.0 | -116.5 | -56.1 | 1,169.9 | -764.4 | 45.4 | 1,431.0 | -798.3 | -70.4 | 2,264.3 | -2,459.2 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 27 | 21 | 27 | 40 | 29 | 20 | 20 | 27 | 23 | 34 | 41 |
Price To Earnings Price To Earnings | 221.5 | 437.5 | 0.0 | 0.0 | 95.0 | 49.2 | 0.8 | 9.4 | 18.7 | 8.2 | 7.8 |
Price To Sales Price To Sales | | | | | | | | | | 83.8 | 15.5 |
Price To Book Price To Book | 0.7 | 0.6 | 0.7 | 1.1 | 0.8 | 0.5 | 0.3 | 0.4 | 0.3 | 0.5 | 0.5 |
| -34.3 | -21.7 | -27.6 | -23.4 | -9.4 | -2.5 | -4.5 | 2.7 | 6.5 | -19.6 | 1.1 |
Profitability Ratios Profitability Ratios |
| | | | | | | | | | 2.4 | 0.8 |
| | | | | | | | | | -423.4 | -55.6 |
| | | | | | | | | | 1,025.2 | 198.7 |
| 0.6 | 0.1 | -0.6 | -1.5 | 2.0 | 2.2 | 39.4 | 5.9 | 3.8 | 7.5 | 8.9 |
| 0.3 | 0.1 | -0.6 | -3.2 | 0.8 | 1.1 | 38.4 | 4.3 | 1.9 | 5.6 | 6.6 |
| 0.3 | 0.1 | -0.6 | -3.2 | 0.8 | 1.1 | 38.1 | 4.3 | 1.9 | 5.5 | 6.5 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Transchem Limited is currently executing a fundamental structural transformation, pivoting from its historical roots in **Pharmaceuticals, Biotechnology, and Mushroom production** toward a technology-driven **Financial Services** ecosystem. Following the monetization of its Pune-based export facility in **FY 2020-21**, the company has aggressively restructured its corporate objectives, capital base, and leadership location to establish itself as a comprehensive fintech and investment services provider.
---
### **Strategic Reorientation: The Pivot to Financial Services**
The company has formally amended its **Memorandum of Association (MoA)** to shift its core business focus. The new roadmap transitions Transchem from a manufacturing and trading entity into a diversified financial intermediary.
**Core Service Verticals:**
* **Stock Broking & Trading:** Full-spectrum trading capabilities across Equities (**BSE & NSE**), Derivatives, Currencies, and Commodities.
* **Depository Services:** Operationalizing as a **CDSL Depository Participant (DP)**.
* **Investment Distribution:** Third-party distribution of **IPOs, Mutual Funds, and Exchange Traded Funds (ETFs)**.
* **Asset & Wealth Management:** Acting as a Sponsor or Trustee for investment funds; providing Portfolio Management Services (PMS) and Investment Banking.
* **Research & Advisory:** Publication of equity research reports and technology-led investment advisory.
* **Fintech Integration:** Deployment of **Artificial Intelligence (AI) and Machine Learning (ML)** to optimize trading algorithms and service delivery.
---
### **Capital Structure & Massive Fundraise Initiative**
To facilitate this transition, Transchem has initiated a significant capital expansion program, increasing its financial flexibility to pursue acquisitions and infrastructure development.
| Metric | Details |
| :--- | :--- |
| **Authorized Share Capital** | Increased from **₹30 Crore** to **₹75 Crore** (Dec 2025) |
| **Paid-up Equity Capital** | **₹12.24 Crore** (1,22,40,000 shares at ₹10 par) |
| **Preferential Issue Size** | Up to **6,15,00,000 Warrants** |
| **Issue Price per Warrant** | **₹75.00** |
| **Total Fund Raise Target** | Up to **₹461.25 Crore** |
| **Warrant Payment Terms** | **25%** (₹18.75) upfront; **75%** (₹56.25) within **18 months** |
| **Investment Limit (Sec 186)** | Enhanced to **₹250 Crore** for loans and acquisitions |
**Utilization of Proceeds:**
1. **Strategic Acquisitions:** Funding the **100% equity acquisition** of **Greshma Shares & Stocks Limited (GSSL)** to immediately onboard broking and DP licenses.
2. **Fintech Ventures:** Investing in digital platforms and allied financial technology startups.
3. **Interim Treasury Management:** Pending final deployment, funds are managed via **short-term treasury operations**, including liquid mutual funds and government securities.
---
### **Financial Performance & Growth Trajectory**
The company has maintained a debt-free profile with a steady appreciation in net worth, primarily driven by internal accruals and disciplined capital management.
**Three-Year Financial Summary:**
| Metric | FY 2024-25 | FY 2023-24 | FY 2022-23 |
| :--- | :--- | :--- | :--- |
| **Total Revenue** (₹ Lakhs) | *In Progress* | **780.70** | **424.45** |
| **Net Worth** (₹ Crores) | **79.32** | **75.64** | **65.84** |
| **Earnings Per Share (EPS)** (₹) | - | **3.43** | **1.01** |
| **Net Worth Growth (%)** | **4.85%** | **14.88%** | - |
*Note: The Board has opted **not to recommend a dividend**, prioritizing the conservation of cash for the ongoing strategic expansion.*
---
### **Operational Infrastructure & Governance**
* **Corporate Relocation:** In August 2025, the Registered Office was moved to **Nariman Point, Mumbai**. This move centralizes operations within India’s financial hub and aligns the company with other **Promoter Group entities**.
* **Digital Transition:** As of March 2025, **89.80%** of equity shares are held in dematerialized form.
* **Legacy/Ancillary Business:** While the focus is financial services, the company maintains a trading relationship with **Manegrow Agro Products Private Limited**, with a transaction ceiling of **₹12.00 Crore** for FY 2025-26.
* **Compliance Framework:** Reporting follows **Ind-AS 108** (currently a single operating segment). Shareholder services are managed by **MUFG Intime India Private Limited**.
---
### **Risk Matrix & Mitigation Strategies**
Transchem’s transition occurs against a volatile macroeconomic backdrop. The company utilizes a formal **Risk Management Policy** and **Vigil Mechanism** to navigate these challenges.
**External Risk Factors:**
* **Macroeconomic Volatility:** Rising financing costs and **RBI monetary tightening** to curb inflation may impact the scalability of the new financial services vertical.
* **Global Trade Headwinds:** A projected **0.2% decline** in global merchandise trade (WTO) and increased protectionism could affect broader market liquidity.
* **Geopolitical Instability:** Regional tensions contribute to **market volatility**, potentially impacting the valuation of the company’s treasury holdings and the performance of its future broking business.
* **Climate Dependency:** While the **Southwest Monsoon** is forecasted at **105% of the Long Period Average (LPA)**, localized deficits could impact the rural economy and the company's residual agricultural trading interests.
**Internal Governance:**
To prevent mismanagement during this high-growth phase, the company enforces a **Whistle Blower Policy** under **Regulation 22 of SEBI Listing Regulations**. The **Audit Committee** maintains oversight of all related-party transactions and internal control systems to ensure transparency during the deployment of the **₹461.25 Crore** capital raise.